CCL5/CCR5 axis in human diseases and related treatments

Zhen Zeng; Tianxia Lan; Yuquan Wei; Xiawei Wei

doi:10.1016/j.gendis.2021.08.004

您当前的位置：

首页 >

文章列表页 >

CCL5/CCR5 axis in human diseases and related treatments

更新时间：2022-06-24

- CCL5/CCR5 axis in human diseases and related treatments
- Genes & Diseases Vol. 9, Issue 1, (2022)
- 作者机构：
  
  Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road,Sichuan,Chengdu,PR China,610041
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.08.004
  CLC：
- Published：2022，
  
  Published Online：1 January 2022，
扫描看全文
Zhen Zeng, Tianxia Lan, Yuquan Wei, et al. CCL5/CCR5 axis in human diseases and related treatments. [J]. Genes & Diseases 9(1).(2022)
DOI：

Zhen Zeng, Tianxia Lan, Yuquan Wei, et al. CCL5/CCR5 axis in human diseases and related treatments. [J]. Genes & Diseases 9(1).(2022) DOI： 10.1016/j.gendis.2021.08.004.

摘要

Abstract

To defense harmful stimuli or maintain the immune homeostasis

the body produces and recruits a superfamily of cytokines such as interleukins

interferons

chemokines etc. Among them

chemokines act as crucial regulators in defense systems. CCL5/CCR5 combination is known for facilitating inflammatory responses

as well as inducing the adhesion and migration of different T cell subsets in immune responses. In addition

recent studies have shown that the interaction between CCL5 and CCR5 is involved in various pathological processes including inflammation

chronic diseases

cancers as well as the infection of COVID-19. This review focuses on how CCL5/CCR5 axis participates in the pathological processes of different diseases and their relevant signaling pathways for the regulation of the axis. Moreover

we highlighted the gene therapy and chemotherapy studies for treating CCR5-related diseases

including the ongoing clinical trials. The barriers and perspectives for future application and translational research were also summarized.

关键词

Keywords

CancerCCL5/CCR5InfectionTherapy

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer

IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment

DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer

De novo nucleotide biosynthetic pathway and cancer

Multiple regulatory roles of the transfer RNA-derived small RNAs in cancers

Related Author

David Sánchez-Marín

Macrina Beatriz Silva-Cázares

Fany Iris Porras-Reyes

Rebeca García-Román

Alma D. Campos-Parra

Meiqi Duan

Haiyang Liu

Shasha Xu

Related Institution

Posgrado en Ciencias Biológicas, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, C.P. 04360, México

Instituto de Salud Pública, Universidad Veracruzana (UV), Av. Dr Luis, Dr. Castelazo Ayala s/n, Col. Industrial Ánimas, Xalapa, Veracruz, C.P. 91190, México

Servicio de Anatomía Patológica, Instituto Nacional de Cancerología (INCan), Niño Jesús, Tlalpan, Ciudad de México, C.P. 14080, México

Unidad Académica Multidisciplinaria Región Altiplano, Universidad Autónoma de San Luis Potosí (UASLP), Carretera a Cedral Km 5+600, Ejido San José de la Trojes, Matehuala, San Luis Potosí, C.P. 78760, México

Department of General Surgery, The Fourth Affiliated Hospital of China Medical University

⁰